Advertisement
Screener

IMMUNOVANT, INC. (IMVT) Outstanding Bonds: Outstanding

IMMUNOVANT, INC. Outstanding Bonds

Note series still outstanding, nearest maturity first. Terms are from each offering's final pricing term sheet on SEC EDGAR; a reopening of the same CUSIP adds to its principal. Interest per payment = principal × coupon ÷ payments per year. Outstanding = principal issued minus each filed exchange, tender, redemption or conversion; it is (m) where the retired amount was not filed. Interest per payment uses the outstanding principal.

NotesPrincipal issuedOutstandingCouponTrade dateIssue / settlement dateMaturity dateInterest payment datesInterest per paymentAnnual coupon interestOptional redemptionRetiredPriced

Similar stocks

Stock NameCountryMarket CapPE Ratio
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56